Omniscope
PrivateLast Round
Early Funding
Feb 25, 2025
Total Funding Raised
$6.28M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Omniscope is a biotechnology company that develops an artificial intelligence-based platform to decode the immune system for diagnostic and therapeutic purposes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical AI, Precision Medicine, Healthcare Analytics, Sports & Fitness
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Omniscope Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Omniscope Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Feb 25, 2025 | ||||
| Grant | Jan 1, 2024 | ||||
| Seed | Jun 1, 2023 | ||||
| Grant | Sep 1, 2022 | ||||
| Seed | Oct 1, 2021 |
Omniscope Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Commission | Grant |
| FoundersX Ventures | Early Funding, Seed |
| Buenavista Equity Partners | Early Funding |
| Barça Innovation Hub | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 22, 2026
Partnered with barnaclínic+ on AI-driven immune decoding for sports medicine.
- Apr 22, 2026
Launched AI-driven immune decoding technology with barnaclínic+.
Omniscope Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Omniscope's valuation, stock price, and market status.